Proprietary Ionizable Lipids-Based LNP for Muscle-Selective Gene Delivery With Minimized Systemic Exposure via Local Administration

Time: 12:00 pm
day: Conference Day One


  • Developing novel ionizable lipids for next-generation of LNP for muscle-selective gene delivery
  • Enhancing locally restricted gene delivery with a notable reduction in undesired systemic exposure
  • Enabling the development of mRNA vaccines for infectious diseases and cancer with reduced adverse events